The Business Research Company The Business Research Company's Immersive Simulator Global Market Set For Rapid Expansion; Projected To Reach ...

Illumina, Inc. ILMN recently entered into a definitive agreement with Standard BioTools LAB to acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets. The ...

Illumina expects to close the transaction in the first half of 2026. Until then, the companies will continue to operate as separate and independent entities. Goldman Sachs and Co. LLC is serving as ...

SAN DIEGO, June 25, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced it has entered into a definitive agreement with Standard BioTools (NASDAQ: LAB) under which Illumina will acquire ...

Dr. Lal PathLabs Limited announces the addition of Illumina’s NovaSeq X Series to enhance genomic testing capabilities, promising faster and more accurate genomic insights with unprecedented ...

“As Illumina continues to grow in India, we are committed to democratizing access to sequencing technologies. NovaSeq X Series represents our leadership in next-generation sequencing, and we are ...

Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.

The saga between Illumina and Grail reaches its conclusion as divestment is enforced following legal proceedings with the European Commission and US Federal Trade Commission.

CBS News contributor and Democratic strategist Chuck Rocha and Republican strategist Rina Shah join "The Takeout" to discuss.